Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Testing effectiveness (Phase 2)Study completedNCT01689766
What this trial is testing

Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Endocyte 150
Early research (Phase 1)Active Not RecruitingNCT05614102
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 284
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07101900
What this trial is testing

68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT03991130
What this trial is testing

High Dose IL-2 in Combination With Anti-PD-1

Who this might be right for
MelanomaRenal Cell Carcinoma, Metastatic
Gregory Daniels 6
Large-scale testing (Phase 3)Study completedNCT03138512
What this trial is testing

A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney

Who this might be right for
Carcinoma, Renal Cell
Bristol-Myers Squibb 1,641
Early research (Phase 1)Study completedNCT02498665
What this trial is testing

DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesGlioblastoma Multiforme+6 more
Sumitomo Pharma America, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT01793636
What this trial is testing

A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Carcinoma
Queen Mary University of London 49
Testing effectiveness (Phase 2)Study completedNCT00278395
What this trial is testing

Vorinostat in Treating Patients With Kidney Cancer

Who this might be right for
Recurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT00782275
What this trial is testing

Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Beth Israel Deaconess Medical Center 41
Very early researchStudy completedNCT00884520
What this trial is testing

An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037

Who this might be right for
Lung CancerSquamous Cell CarcinomaHead and Neck Cancer+2 more
Siemens Molecular Imaging 16
Testing effectiveness (Phase 2)Study completedNCT04090710
What this trial is testing

SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Ontario Clinical Oncology Group (OCOG) 66
Testing effectiveness (Phase 2)UnknownNCT04913025
What this trial is testing

REduced Frequency ImmuNE Checkpoint Inhibition in Cancers

Who this might be right for
Renal Cell CarcinomaMelanoma
University College, London 160
Early research (Phase 1)Study completedNCT01525017
What this trial is testing

A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Mendus 12
Testing effectiveness (Phase 2)Ended earlyNCT04434560
What this trial is testing

Neoadjuvant Immunotherapy in Brain Metastases

Who this might be right for
Brain Metastases, Adult
Sarah Sammons, MD 1
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Not applicableStudy completedNCT00806650
What this trial is testing

Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
City of Hope Medical Center 155
Not applicableLooking for participantsNCT05037825
What this trial is testing

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

Who this might be right for
Non-Small-Cell Lung CarcinomaMalignant MelanomaRenal Cell Carcinoma+1 more
VastBiome 800
Not applicableStudy completedNCT04309617
What this trial is testing

Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy

Who this might be right for
Renal Cell Carcinoma
Pfizer 618
Next Page